We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
307 hedge funds and large institutions have $7.9B invested in Acadia Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 75 funds opening new positions, 93 increasing their positions, 98 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
142% more first-time investments, than exits
New positions opened: 75 | Existing positions closed: 31
29% more funds holding in top 10
Funds holding in top 10: 7 → 9 (+2)
28% more capital invested
Capital invested by funds: $6.17B → $7.9B (+$1.74B)
24% more call options, than puts
Call options by funds: $55.4M | Put options by funds: $44.6M
15% more funds holding
Funds holding: 266 → 307 (+41)
5% less repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 98
1.45% less ownership
Funds ownership: 94.48% → 93.03% (-1.5%)
Holders
307
Holders Change
+41
Holders Change %
+15.41%
% of All Funds
5.43%
Holding in Top 10
9
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+28.57%
% of All Funds
0.16%
New
75
Increased
93
Reduced
98
Closed
31
Calls
$55.4M
Puts
$44.6M
Net Calls
+$10.8M
Net Calls Change
+$23M
Top Buyers
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$96.8M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$44.3M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$41.6M |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$26.2M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$23.3M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$132M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$64.4M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$59.6M |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$39.3M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$30.9M |
